advertisement
12.4 Laser trabeculoplasty and other laser treatment of the angle (16)
Showing records 1 to 16
Search within classification 12.4 Laser trabeculoplasty and other laser treatment of the angle52599 Switching prostaglandin analogues and 24-hour iop fluctuations
Gil-Carrasco F; Turati-Acosta M; Albis-Donado O; Bello-López-Portillo H; Sánchez-Noguera C; Soto-Ortiz K
Archivos de la Sociedad Española de Oftalmologia 2013; 88: 130-133
52909 Results of selective laser trabeculoplasty (SLT) as initial treatment for normal tension glaucoma
Nitta K; Sugiyama K; Mawatari Y; Tanahashi T
Nippon Ganka Gakkai Zasshi 2013; 117: 335-343
52438 Long-term Outcomes of Selective Laser Trabeculoplasty (SLT) Treatment in Pigmentary Glaucoma Patients
Ayala M
Journal of Glaucoma 2014; 23: 616-619
53184 Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins
Giménez-Gómez R; García-Catalán MR; Gallardo-Galera JM
Archivos de la Sociedad Española de Oftalmologia 2013; 88: 88-91
52417 Safety Assessment of Subconjunctivally Implanted Devices Containing Latanoprost in Dutch-Belted Rabbits
Jessen BA; Shiue MH; Kaur H; Miller P; Leedle R; Guo H; Evans M
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 574-585
52415 Corneal endothelial changes after selective laser trabeculoplasty
Ong K; Ong L
Clinical and Experimental Ophthalmology 2013; 41: 537-540
52564 Is the observed lowering of intraocular pressure due to treatment?
Thomas R; Mengersen K
Indian Journal of Ophthalmology 2013; 61: 119-121
53193 Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
Lanzl I; Hamacher T; Rosbach K; Ramez MO; Rothe R; Růžičková E; Karhanová M; Kimmich F
Clinical Ophthalmology 2013; 7: 901-910
52469 Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma
Avery N; Ang GS; Nicholas S; Wells A
International Ophthalmology 2013; 33: 501-506
52586 Mechanisms, clinical profile and role of prostaglandin and prostamide analogues in antiglaucomatous therapy
Yu A; Welge-Lüßen U
Klinische Monatsblätter für Augenheilkunde 2013; 230: 127-132
52395 Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies
Dams I; Wasyluk J; Prost M; Kutner A
Prostaglandins & other lipid mediators 2013; 104: 109-121
52816 Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension
Crichton AC; Vold S; Williams JM; Hollander DA
Advances in Therapy 2013; 30: 260-270
53242 A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features
Shah M; Lee G; Lefebvre DR; Kronberg B; Loomis S; Brauner SC; Turalba A; Rhee DJ; Freitag SK; Pasquale LR
PLoS ONE 2013; 8: e61638
52450 Impact of Age, Diagnosis, and History of Glaucoma Surgery on Outcomes in Pediatric Patients Treated With Latanoprost
Maeda-Chubachi T; Chi-Burris K; Simons B; Brémond-Gignac D; Freedman S; Khaw PT; Wirostko B; Yan E;
Journal of Glaucoma 2013; 22: 614-619
52894 Selective laser trabeculoplasty for the management of open-angle glaucoma in St. Lucia
Realini T
JAMA ophthalmology 2013; 131: 321-327
52657 Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany
Thelen U; Schnober D; Schölzel S; Kristoffersen MS; Nelson LA; Stewart JA; Stewart WC
International Journal of Ophthalmology 2013; 6: 155-159
